UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000032909
Receipt No. R000037524
Official scientific title of the study Measurement accuracy of flash glucose monitoring in postprandial periods
Date of disclosure of the study information 2018/06/07
Last modified on 2018/06/07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Measurement accuracy of flash glucose monitoring in postprandial periods
Title of the study (Brief title) Measurement accuracy of FGM in postprandial periods
Region
Japan

Condition
Condition Japanese adults with type 2
diabetes or impaired glucose tolerance
Classification by specialty
Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the accuracy of flash glucose monitoring in postprandial periods
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes the difference among glucose levels obtained by FGM, capillary blood glucose, and plasma glucose
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Female
Key inclusion criteria individuals with type 2 diabetes or impaired glucose tolerance
Key exclusion criteria individuals with atopic dermatitis
Target sample size 20

Research contact person
Name of lead principal investigator Oka Rie
Organization Kanazawa University Hospital
Division name Endocrinology and Diabetes
Address 13-1 Takara-machi Kanazawa
TEL 076-265-2264
Email ririoka@goo.jp

Public contact
Name of contact person Takamiya Yukiko
Organization Cardiovascular and Internal medicine
Division name Endocrinology and Diabetes
Address 13-1 Takara-machi Kanazawa
TEL 0762652259
Homepage URL
Email dm2ken@yahoo.co.jp

Sponsor
Institute Kanazawa University Hospital
Institute
Department

Funding Source
Organization kanazawa University
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2018 Year 06 Month 07 Day

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2018 Year 03 Month 01 Day
Anticipated trial start date
2018 Year 05 Month 15 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information not particular

Management information
Registered date
2018 Year 06 Month 07 Day
Last modified on
2018 Year 06 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037524

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.